Compare $DMAC vs $OVID | Chartloom

Compare

$DMAC vs $OVID

DiaMedica Therapeutics Inc · Ovid Therapeutics Inc

DMAC

DiaMedica Therapeutics Inc

OVID

Ovid Therapeutics Inc

Compare $DMAC vs $OVID

Comparing DiaMedica Therapeutics Inc and Ovid Therapeutics Inc

DMACDiaMedica Therapeutics Inc

OVIDOvid Therapeutics Inc

DMACDiaMedica Therapeutics Inc

Market cap

$449M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

5.0%

52W performance

19.7%

FCF yield

-7.0%

OVIDOvid Therapeutics Inc

Market cap

$459M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

1,284.26x

Rev growth (TTM)

-76.2%

YTD performance

39.8%

52W performance

55.7%

FCF yield

-11.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DMAC

OVID

Detailed metrics comparison

DMAC

DiaMedica Therapeutics Inc

OVID

Ovid Therapeutics Inc

Market Cap

DMAC$449M

OVID$459M

Enterprise Value

DMAC$444M

OVID$448M

Price

DMAC$8.33

OVID$2.46

P/E Ratio

DMACN/A

OVIDN/A

P/S Ratio

DMAC0.00x

OVID290.04x

EV/Sales

DMAC0.00x

OVID282.89x

EV/EBITDA

DMAC0.00x

OVID3.65x

P/B Ratio

DMAC11.58x

OVID2.21x

P/FCF Ratio

DMACN/A

OVIDN/A

EV/FCF

DMAC-14.07x

OVID-8.18x

PEG Ratio

DMACN/A

OVIDN/A

Forward P/E (NTM)

DMACN/A

OVIDN/A

Forward P/S (NTM)

DMACN/A

OVID1,284.26x

Revenue (TTM)

DMAC$0

OVID$2M

Revenue Growth (YoY)

DMACN/A

OVID-76.2%

Forward Rev Growth

DMAC306.4%

OVID-72.6%

Gross Margin (TTM)

DMAC0.0%

OVID0.0%

Operating Margin (TTM)

DMAC0.0%

OVID0.0%

EBITDA Margin (TTM)

DMAC0.0%

OVID-3681.4%

Net Margin (TTM)

DMAC0.0%

OVID-2178.9%

FCF Margin (TTM)

DMACN/A

OVID-3460.1%

Net Income (TTM)

DMAC$-38M

OVID$-34M

FCF (TTM)

DMAC$-32M

OVID$-55M

EPS (TTM)

DMAC-$0.70

OVID-$0.17

ROE (TTM)

DMAC-7768.0%

OVID-2364.0%

ROA (TTM)

DMAC-6936.0%

OVID-2052.0%

ROIC (TTM)

DMAC-7766.0%

OVID-2364.0%

Cash

DMAC$5M

OVID$11M

Debt

DMAC$9K

OVID$0

Net Cash/Debt

DMAC$5M

OVID$11M

Current Ratio (TTM)

DMAC6.72x

OVID12.39x

Quick Ratio (TTM)

DMAC6.63x

OVID11.75x

Debt/Equity (TTM)

DMAC0.00x

OVID0.00x

Debt/Assets (TTM)

DMAC0.0%

OVID0.0%

Interest Coverage (TTM)

DMACN/A

OVIDN/A

Net Debt/EBITDA (TTM)

DMAC0.00x

OVID0.00x

Beta

DMAC0.96

OVID0.28

52W Performance

DMAC19.7%

OVID55.7%

YTD Performance

DMAC5.0%

OVID39.8%

% from 52W High

DMAC-20.1%

OVID-20.8%

% from 52W Low

DMAC58.8%

OVID108.5%

Asset Turnover (TTM)

DMAC0.00x

OVID0.01x

FCF Yield (TTM)

DMAC-7.0%

OVID-11.9%

Earnings Yield (TTM)

DMAC-8.4%

OVID-7.5%

Dividend Yield (TTM)

DMACN/A

OVIDN/A

Rule of 40

DMAC0.0

OVID-3,536.3

EV/GP/RG

DMACN/A

OVIDN/A

Ticker research

View DMAC research View OVID research

Metric	DMAC DiaMedica Therapeutics Inc	OVID Ovid Therapeutics Inc
Market & Valuation
Market Cap	$449M	$459M
Enterprise Value	$444M	$448M
Price	$8.33	$2.46
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	290.04x
EV/Sales	0.00x	282.89x
EV/EBITDA	0.00x	3.65x
P/B Ratio	11.58x	2.21x
P/FCF Ratio	N/A	N/A
EV/FCF	-14.07x	-8.18x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	1,284.26x
Revenue & Growth
Revenue (TTM)	$0	$2M
Revenue Growth (YoY)	N/A	-76.2%
Forward Rev Growth	306.4%	-72.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-3681.4%
Net Margin (TTM)	0.0%	-2178.9%
FCF Margin (TTM)	N/A	-3460.1%
Net Income (TTM)	$-38M	$-34M
FCF (TTM)	$-32M	$-55M
EPS (TTM)	-$0.70	-$0.17
ROE (TTM)	-7768.0%	-2364.0%
ROA (TTM)	-6936.0%	-2052.0%
ROIC (TTM)	-7766.0%	-2364.0%
Financial Health
Cash	$5M	$11M
Debt	$9K	$0
Net Cash/Debt	$5M	$11M
Current Ratio (TTM)	6.72x	12.39x
Quick Ratio (TTM)	6.63x	11.75x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.96	0.28
52W Performance	19.7%	55.7%
YTD Performance	5.0%	39.8%
% from 52W High	-20.1%	-20.8%
% from 52W Low	58.8%	108.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-7.0%	-11.9%
Earnings Yield (TTM)	-8.4%	-7.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-3,536.3
EV/GP/RG	N/A	N/A
Ticker research	View DMAC research	View OVID research

Valuation

P/S Ratio

DMAC

0.00x

OVID

290.04x

EV/FCF

DMAC

-14.07x

OVID

-8.18x

Growth & revenue

Revenue Growth TTM

OVID

-76.2%

Forward Revenue Growth

DMAC

306.4%

OVID

-72.6%

Profitability & performance

Gross Margin

DMAC

0.0%

OVID

0.0%

ROE

OVID

-2364.0%

DMAC

-7768.0%

FCF Yield %

DMAC

-7.0%

OVID

-11.9%

52-Week Performance

OVID

55.7%

DMAC

19.7%

Detailed metrics comparison

DMAC

DiaMedica Therapeutics Inc

OVID

Ovid Therapeutics Inc

Market Cap

DMAC$449M

OVID$459M

Enterprise Value

DMAC$444M

OVID$448M

Price

DMAC$8.33

OVID$2.46

P/E Ratio

DMACN/A

OVIDN/A

P/S Ratio

DMAC0.00x

OVID290.04x

EV/Sales

DMAC0.00x

OVID282.89x

EV/EBITDA

DMAC0.00x

OVID3.65x

P/B Ratio

DMAC11.58x

OVID2.21x

P/FCF Ratio

DMACN/A

OVIDN/A

EV/FCF

DMAC-14.07x

OVID-8.18x

PEG Ratio

DMACN/A

OVIDN/A

Forward P/E (NTM)

DMACN/A

OVIDN/A

Forward P/S (NTM)

DMACN/A

OVID1,284.26x

Revenue (TTM)

DMAC$0

OVID$2M

Revenue Growth (YoY)

DMACN/A

OVID-76.2%

Forward Rev Growth

DMAC306.4%

OVID-72.6%

Gross Margin (TTM)

DMAC0.0%

OVID0.0%

Operating Margin (TTM)

DMAC0.0%

OVID0.0%

EBITDA Margin (TTM)

DMAC0.0%

OVID-3681.4%

Net Margin (TTM)

DMAC0.0%

OVID-2178.9%

FCF Margin (TTM)

DMACN/A

OVID-3460.1%

Net Income (TTM)

DMAC$-38M

OVID$-34M

FCF (TTM)

DMAC$-32M

OVID$-55M

EPS (TTM)

DMAC-$0.70

OVID-$0.17

ROE (TTM)

DMAC-7768.0%

OVID-2364.0%

ROA (TTM)

DMAC-6936.0%

OVID-2052.0%

ROIC (TTM)

DMAC-7766.0%

OVID-2364.0%

Cash

DMAC$5M

OVID$11M

Debt

DMAC$9K

OVID$0

Net Cash/Debt

DMAC$5M

OVID$11M

Current Ratio (TTM)

DMAC6.72x

OVID12.39x

Quick Ratio (TTM)

DMAC6.63x

OVID11.75x

Debt/Equity (TTM)

DMAC0.00x

OVID0.00x

Debt/Assets (TTM)

DMAC0.0%

OVID0.0%

Interest Coverage (TTM)

DMACN/A

OVIDN/A

Net Debt/EBITDA (TTM)

DMAC0.00x

OVID0.00x

Beta

DMAC0.96

OVID0.28

52W Performance

DMAC19.7%

OVID55.7%

YTD Performance

DMAC5.0%

OVID39.8%

% from 52W High

DMAC-20.1%

OVID-20.8%

% from 52W Low

DMAC58.8%

OVID108.5%

Asset Turnover (TTM)

DMAC0.00x

OVID0.01x

FCF Yield (TTM)

DMAC-7.0%

OVID-11.9%

Earnings Yield (TTM)

DMAC-8.4%

OVID-7.5%

Dividend Yield (TTM)

DMACN/A

OVIDN/A

Rule of 40

DMAC0.0

OVID-3,536.3

EV/GP/RG

DMACN/A

OVIDN/A

Ticker research

View DMAC research View OVID research

Metric	DMAC DiaMedica Therapeutics Inc	OVID Ovid Therapeutics Inc
Market & Valuation
Market Cap	$449M	$459M
Enterprise Value	$444M	$448M
Price	$8.33	$2.46
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	290.04x
EV/Sales	0.00x	282.89x
EV/EBITDA	0.00x	3.65x
P/B Ratio	11.58x	2.21x
P/FCF Ratio	N/A	N/A
EV/FCF	-14.07x	-8.18x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	1,284.26x
Revenue & Growth
Revenue (TTM)	$0	$2M
Revenue Growth (YoY)	N/A	-76.2%
Forward Rev Growth	306.4%	-72.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-3681.4%
Net Margin (TTM)	0.0%	-2178.9%
FCF Margin (TTM)	N/A	-3460.1%
Net Income (TTM)	$-38M	$-34M
FCF (TTM)	$-32M	$-55M
EPS (TTM)	-$0.70	-$0.17
ROE (TTM)	-7768.0%	-2364.0%
ROA (TTM)	-6936.0%	-2052.0%
ROIC (TTM)	-7766.0%	-2364.0%
Financial Health
Cash	$5M	$11M
Debt	$9K	$0
Net Cash/Debt	$5M	$11M
Current Ratio (TTM)	6.72x	12.39x
Quick Ratio (TTM)	6.63x	11.75x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.96	0.28
52W Performance	19.7%	55.7%
YTD Performance	5.0%	39.8%
% from 52W High	-20.1%	-20.8%
% from 52W Low	58.8%	108.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.01x
FCF Yield (TTM)	-7.0%	-11.9%
Earnings Yield (TTM)	-8.4%	-7.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-3,536.3
EV/GP/RG	N/A	N/A
Ticker research	View DMAC research	View OVID research